Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pediatric residency training on tobacco: training director tobacco survey.
Hymowitz N, Schwab J, Eckholdt H. Hymowitz N, et al. Prev Med. 2001 Dec;33(6):688-98. doi: 10.1006/pmed.2001.0946. Prev Med. 2001. PMID: 11716668
Predictors of smoking cessation in a cohort of adult smokers followed for five years.
Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD. Hymowitz N, et al. Tob Control. 1997;6 Suppl 2(Suppl 2):S57-62. doi: 10.1136/tc.6.suppl_2.s57. Tob Control. 1997. PMID: 9583654 Free PMC article.
The pediatrician's role in reducing tobacco exposure in children.
Stein RJ, Haddock CK, O'Byrne KK, Hymowitz N, Schwab J. Stein RJ, et al. Among authors: hymowitz n. Pediatrics. 2000 Nov;106(5):E66. doi: 10.1542/peds.106.5.e66. Pediatrics. 2000. PMID: 11061803 Review.
Pediatric residency training on tobacco.
Hymowitz N, Schwab J, Eckholdt H. Hymowitz N, et al. Pediatrics. 2001 Jul;108(1):E8. doi: 10.1542/peds.108.1.e8. Pediatrics. 2001. PMID: 11433087
Tobacco control in New Jersey: a public forum on smoking and youth.
Hymowitz N. Hymowitz N. N J Med. 1993 Nov;90(11):836-8. N J Med. 1993. PMID: 8272273
Paterson COMMIT: a smoke-free community initiative.
Hymowitz N. Hymowitz N. N J Med. 1995 Jan;92(1):22-4. N J Med. 1995. PMID: 7854569
A survey of pediatric office-based interventions on smoking.
Hymowitz N. Hymowitz N. N J Med. 1995 Oct;92(10):657-60. N J Med. 1995. PMID: 7478283
Effects of a 2.5-mg silver acetate lozenge on initial and long-term smoking cessation.
Hymowitz N, Eckholdt H. Hymowitz N, et al. Prev Med. 1996 Sep-Oct;25(5):537-46. doi: 10.1006/pmed.1996.0087. Prev Med. 1996. PMID: 8888321 Clinical Trial.
Over 70% of the quitters (n = 70) reported using the lozenge on an as-needed basis for relapse prevention. The overall objectively verified quit rates for subjects assigned to the silver acetate and placebo conditions at Visit 3 (3 weeks) were 17% (n = 42) and 11% ( …
Over 70% of the quitters (n = 70) reported using the lozenge on an as-needed basis for relapse prevention. The overall objectively ve …
The multiple risk factor intervention trial (MRFIT). V. Intervention on smoking.
Hughes GH, Hymowitz N, Ockene JK, Simon N, Vogt TM. Hughes GH, et al. Among authors: hymowitz n. Prev Med. 1981 Jul;10(4):476-500. doi: 10.1016/0091-7435(81)90061-x. Prev Med. 1981. PMID: 7027239 Clinical Trial. No abstract available.
Smokers' baseline characteristics in the COMMIT trial.
Hymowitz N, Corle D, Royce J, Hartwell T, Corbett K, Orlandi M, Piland N. Hymowitz N, et al. Prev Med. 1995 Sep;24(5):503-8. doi: 10.1006/pmed.1995.1080. Prev Med. 1995. PMID: 8524726
61 results
Jump to page
Feedback